Ivantis reveals HYDRUS II study results for glaucoma July 24, 2013 By Omar Ford Even though Ivantis' (Irvine, California) Hydrus Microstent has yet to gain FDA approval, word of the device is growing, and the company is developing a body of strong clinical results surrounding the technology.Read More
Washington roundup: FDA says Prodigy Diabetes distributed failing test strips July 24, 2013 By Mark McCarty
NewCo on the Go: Ignyta's combo drug/diagnostics strategy seen as a differentiator July 23, 2013 By Marie Powers
Washington roundup: Providers feeling the squeeze from meaningful use, ICD-10 July 23, 2013 By Mark McCarty
RSS